# First-in-human Study of MRT-6160 in Healthy Subjects

> **NCT06597799** · PHASE1 · COMPLETED · sponsor: **Monte Rosa Therapeutics, Inc** · enrollment: 108 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MRT-6160
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06597799
- **Lead sponsor:** Monte Rosa Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-07
- **Primary completion:** 2025-04-10
- **Final completion:** 2025-04-10
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597799, "First-in-human Study of MRT-6160 in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06597799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*